Skip to content

Study · Not a test of the peptide alone · 2019

3 results

Treatment of HER2+ metastatic salivary ductal carcinoma in a pregnant woman: a case report.

Bergamini C, Cavalieri S, Sanguineti G, Farneti A, Licitra L

Oxford medical case reports31 Oct 2019Cited by 6 (Europe PMC)

PMID31772741 (opens in a new tab)PMCIDPMC6822604 (opens in a new tab)DOI10.1093/omcr/omz102 (opens in a new tab)PepBankPUB-31772741
Read at sourcePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  1. 01HumanNot a test of Triptorelin (Trelstar, Decapeptyl) aloneCase report or seriesEfficacy outcome

    In a woman with metastatic salivary duct carcinoma, complete remission occurred during multimodal treatment including chemotherapy and postpartum triptorelin.

    In plain wordsIn a woman with metastatic salivary duct carcinoma, complete remission occurred during multimodal treatment including triptorelin.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    Not applicableComplete remission
    Study

    n = 1

    Outcome group
    Tumor growth · Cancer

    Source sentences

    Summary
    A complete remission was observed, and after eight cycles of chemotherapy, radiotherapy was started in association with trastuzumab and triptorelin.
    3 context sentences
    Summary · context
    During pregnancy, a 27-year-old woman developed SDC of the left submandibular gland with lung and bone metastases.
    Summary · context
    Given the HER2 overexpression, she was treated with trastuzumab, paclitaxel and cisplatin.
    Summary · context
    Since the tumor had arisen during pregnancy, triptorelin was administered after delivery.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  2. 02HumanNot a test of Triptorelin (Trelstar, Decapeptyl) aloneCase report or seriesEfficacy outcome

    In a woman with metastatic salivary duct carcinoma, prolonged disease control was observed alongside multimodal treatment including trastuzumab, radiotherapy, and triptorelin.

    In plain wordsIn a woman with metastatic salivary duct carcinoma, prolonged disease control was seen alongside multimodal treatment including triptorelin.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    Not applicableProlonged disease control
    Study

    n = 1

    Outcome group
    Tumor growth · Cancer

    Source sentences

    Summary
    A prolonged disease control and complete visceral remission were observed.
    4 context sentences
    Summary · context
    A complete remission was observed, and after eight cycles of chemotherapy, radiotherapy was started in association with trastuzumab and triptorelin.
    Summary · context
    During pregnancy, a 27-year-old woman developed SDC of the left submandibular gland with lung and bone metastases.
    Summary · context
    Given the HER2 overexpression, she was treated with trastuzumab, paclitaxel and cisplatin.
    Summary · context
    Since the tumor had arisen during pregnancy, triptorelin was administered after delivery.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  3. 03HumanNot a test of Triptorelin (Trelstar, Decapeptyl) aloneCase report or seriesEfficacy outcome

    In a woman with metastatic salivary duct carcinoma, complete visceral remission occurred after multimodal treatment including trastuzumab, radiotherapy, and triptorelin.

    In plain wordsIn a woman with metastatic salivary duct carcinoma, complete visceral remission occurred after multimodal treatment including triptorelin.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    Not applicableComplete visceral remission
    Study

    n = 1

    Outcome group
    Tumor growth · Cancer

    Source sentences

    Summary
    A prolonged disease control and complete visceral remission were observed.
    4 context sentences
    Summary · context
    A complete remission was observed, and after eight cycles of chemotherapy, radiotherapy was started in association with trastuzumab and triptorelin.
    Summary · context
    During pregnancy, a 27-year-old woman developed SDC of the left submandibular gland with lung and bone metastases.
    Summary · context
    Given the HER2 overexpression, she was treated with trastuzumab, paclitaxel and cisplatin.
    Summary · context
    Since the tumor had arisen during pregnancy, triptorelin was administered after delivery.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.